Social media has disrupted how diplomats communicate with each other and the general public. How are diplomats using these platforms? How will future digital tools change the meaning and capabilities of digital diplomacy? Gateway House presents an educational mini-series on digital diplomacy, profiling Indian digital diplomacy, and the future trajectory of digital diplomacy.
Earlier this year, Gilead Sciences, a California-based pharmaceutical company, made the headlines for an unusual, positive move in the fraught property rights space. It entered into a license agreement with seven Indian pharmaceutical companies to manufacture lower cost versions of Sovaldi, its popular Hepatitis C drug
Uber’s success allowed it to raise close to $1.2 billion dollars in its last round of investments which means that even as technology changes lives and businesses break new ground, the balance between forging into the future and having an adaptive regulatory environment is the need of the hour
Space exploration may take a hit as terrestrial politics plays spoilsport with the U.S. government spearheading a sanctions programme against Russia. With China pursuing an independent space programme of its own, Russia’s departure from the effort may mark the beginning of a divided space once again after the Cold War
Yusuf K. Hamied, the chairman of Cipla, talks about the forthcoming meeting between Prime Minister Narendra Modi and U.S. President Barack Obama. Speaking to Gateway House, he says he expects Obama to put pressure on India to change its position on patents
The UN’s Transparency and Confidence Building Measures for Outer Space Activities to address terrestrial anti-satellite weapons have spawned schismatic instruments such as the EU’s International Code of Conduct and a Sino-Russian treaty. India must weigh its national interests before agreeing to these drafts
The issue of foreign direct investment in pharmaceuticals has come under attack from many lobbies. The answers lie in the public sector or public distribution mechanisms. Addressing public health concerns without vitiating the investment climate must be one of the key priorities of the next government